Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
about
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseMannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.In vivo sustained release of siRNA from solid lipid nanoparticles.Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticlesMannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapyDesign of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity.Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.Lipid nanoparticles for cancer therapy: state of the art and future prospects.Oral bioavailability: issues and solutions via nanoformulations.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.Rafts, Nanoparticles and Neural DiseaseIn vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin.Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir.Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles.Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells.Preparation and drug controlled release of porous octyl-dextran microspheres.Physico-chemical characterisation, cytotoxic activity, and biocompatibility studies of tamoxifen-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification method.pH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapy
P2860
Q28073219-82781ED7-6AE8-4340-B74C-6DAD00C647A5Q31151834-FC338592-72C4-45A9-B7AE-D7973C07E0F9Q33862052-40B5B338-7C74-4F36-A80D-0C1EDB6E2B85Q35635763-B9DBFAF1-5967-4DCD-BAB9-8199A366AB5DQ35891741-3927933A-89FB-4DAD-A246-2FCA590609DCQ36148565-4ED7C043-F07B-4E75-BC8B-5BD13404366AQ36452190-DC12D6D5-BE1E-421F-A7D7-EB91BAA90CB4Q37003811-68889091-07C3-4478-9BF9-A284FFF099BAQ37146028-3148CECD-7454-4D60-9472-564B1F98C393Q37158892-3BC54E93-D2EB-4CDE-9103-4F1A2F05B3B6Q37495209-18D96327-E1B7-40FF-B1BD-FFE619694D21Q37716468-B7956E83-D486-4DAE-B90A-425C2CCDB74DQ37914880-3ABAADAC-DB38-42E7-83A3-98F7AB2C562CQ37996097-A762187C-2FE8-4355-B1F2-1B2F0CDB606DQ38040884-FB078747-2271-4ED5-86B1-EA1AC1A8532DQ38349734-5FA2BCE3-293B-4CC4-83CE-73D6B424DCB5Q38558905-9C9F96D4-BE38-46FF-801A-EDD4E003BED1Q38955149-43AF0B6D-9171-4CB6-9788-0B13975C0DB8Q39030165-40E802FF-A872-4895-89CA-E2F96E74E945Q39203564-2E6D509B-1B5A-4D58-83F5-1AE5CAC86751Q39357778-19C90745-CD4F-4880-B664-FA75FA5F64E5Q44506744-86CCDCBC-59FC-44F6-9641-5D327C4D4B51Q45787137-C4486C0E-A6E5-43E8-A8BA-C19001EAD8A0Q47929053-A657DADA-E34B-44E6-B817-6D5F1FE2B719Q48032111-28DA8DA0-5961-4B5D-990D-F2A97A8EF745Q48606369-BD1721CC-4E16-40F2-A3AB-5E7D1C795939Q50080746-02942E8D-1567-4C61-9734-275B9876A0F8Q51826670-3B9C06D6-A901-4A50-9B4B-2C651812CC79Q53059464-E77B3B88-D160-42F5-A09E-84CBF81A32DDQ57376897-42F9471B-87F5-4525-9F04-F1C74ADB81AD
P2860
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@en
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@nl
type
label
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@en
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@nl
prefLabel
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@en
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@nl
P2093
P1476
Mannosylated solid lipid nanop ...... livery of an anti-cancer drug.
@en
P2093
Abhinav Agarwal
Anil Khaya
Ashay Jain
Govind P Agrawal
Himanshu Agrawal
Narendra Lariya
Saikat Majumder
Subrata Majumdar
P304
P356
10.1016/J.JCONREL.2010.09.003
P407
P577
2010-09-17T00:00:00Z